Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Total Current Liabilities: 2014-2025

Historic Total Current Liabilities for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $586.0 million.

  • Surgery Partners' Total Current Liabilities rose 187.76% to $586.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $586.0 million, marking a year-over-year increase of 187.76%. This contributed to the annual value of $624.4 million for FY2024, which is 1938.81% up from last year.
  • As of Q3 2025, Surgery Partners' Total Current Liabilities stood at $586.0 million, which was up 187.76% from $573.3 million recorded in Q2 2025.
  • Surgery Partners' Total Current Liabilities' 5-year high stood at $624.4 million during Q4 2024, with a 5-year trough of $458.6 million in Q2 2023.
  • For the 5-year period, Surgery Partners' Total Current Liabilities averaged around $543.5 million, with its median value being $540.5 million (2021).
  • As far as peak fluctuations go, Surgery Partners' Total Current Liabilities skyrocketed by 3961.62% in 2021, and later plummeted by 1968.6% in 2023.
  • Quarter analysis of 5 years shows Surgery Partners' Total Current Liabilities stood at $536.8 million in 2021, then fell by 8.08% to $493.4 million in 2022, then grew by 6.0% to $523.0 million in 2023, then rose by 19.39% to $624.4 million in 2024, then dropped by 6.15% to $586.0 million in 2025.
  • Its last three reported values are $586.0 million in Q3 2025, $573.3 million for Q2 2025, and $569.4 million during Q1 2025.